TrialBMC infectious diseases2022

2-deoxy-D-glucose as an adjunct to standard of care in the medical management of COVID-19: a proof-of-concept and dose-ranging randomised phase II clinical trial.

Anant Narayan Bhatt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.